Journal Of Experimental & Clinical Cancer Research

SCI SCIE

国际简称：J EXP CLIN CANC RES 参考译名：实验与临床癌症研究杂志

主要研究方向：医学-肿瘤学非预警期刊审稿周期：约1月

《实验与临床癌症研究杂志》(Journal Of Experimental & Clinical Cancer Research)是一本由BioMed Central出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
317 年发文量
14.3 IF影响因子
开放是否OA
67 H-index
2008 创刊年份
Quarterly 出版周期
English 出版语言

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.

[ 查看全部 ]

投稿咨询加急咨询

Journal Of Experimental & Clinical Cancer Research期刊信息

ISSN：1756-9966
出版语言：English
是否OA：开放
E-ISSN：1756-9966
出版地区：ITALY
是否预警：否
出版商：BioMed Central
出版周期：Quarterly
创刊时间：2008
开源占比：0.9955
Gold OA文章占比：99.89%
OA被引用占比：1
出版国人文章占比：0.61
出版撤稿占比：0.0119...
研究类文章占比：85.17%

Journal Of Experimental & Clinical Cancer Research CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

22.3

3.731

2.265

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	17 / 428	96%
大类：Medicine 小类：Cancer Research	Q1	13 / 233	94%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Journal Of Experimental & Clinical Cancer Research中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	ONCOLOGY 肿瘤学	1区

Journal Of Experimental & Clinical Cancer Research JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	23 / 333	93.2
学科：ONCOLOGY	SCIE	Q1	20 / 333	94.14

Journal Of Experimental & Clinical Cancer Research历年数据统计

影响因子

中科院分区

Journal Of Experimental & Clinical Cancer Research中国学者发文选摘

1、Ferrodoxin 1 (FDX1) drives paclitaxel resistance in ovarian cancer via copper metabolism and ULK1/ATG13-mediated autophagy: overcome by pH/ROS-responsive PPD/PDP@si-FDX1 nanomicelle
Author: Gong, Yangmei; Deng, Zhizhi; Wu, Jie; Hu, Yi

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-025-03589-z
2、Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling (Vol 38, 426, 2019
Author: Ou, Baochi; Sun, Hongze; Zhao, Jingkun; Xu, Zhuoqing; Liu, Yuan; Feng, Hao; Peng, Zhihai

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03714-6
3、Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway (vol 37, 41, 2018
Author: Hu, Xiang; Li, Ya-Qi; Li, Qing-Guo; Ma, Yan-Lei; Peng, Jun-Jie; Cai, San-Jun

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03704-8
4、RETRACTION: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathwa
Author: Liu, Bing; Pan, Shimeng; Xiao, Yang; Liu, Qianqian; Xu, Jingchao; Jia, Li

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03700-y
5、UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1 (vol 38, 297, 2019
Author: Chen, Hongze; Li, Le; Hu, Jisheng; Zhao, Zhongjie; Ji, Liang; Cheng, Chundong; Zhang, Guangquan; Zhang, Tao; Li, Yilong; Chen, Hua; Pan, Shangha; Sun, Bei

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03696-5
6、Engineering CLL-1 CAR-NK cells via mRNA-LNP for potent antitumor activity and reversal of HLA-E-mediated resistance in acute myeloid leukemi
Author: Shen, Jie; Jin, Peng; Liang, Yebing; Zhu, Jinyang; Xiang, Rufang; Li, Zeyi; Zhu, Hongming; Li, Xiaoyang; Zhang, Yunxiang; Wang, Wei; Jin, Zhen; Li, Junmin

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03689-4
7、Repurposing dronedarone induces ferroptosis through GPX4 inactivation and degradation in pancreatic cance
Author: Gu, Yanmei; Wang, Yingying; Liu, Gangli; Cui, Rong; Ma, Chenzhe; Wang, Jianrong; Gao, Xing; Zhao, Yang; Li, Yumin

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03687-6
8、LARS promotes osteosarcoma proliferation through leucine-dependent PRIM2 translation and DNA replication activatio
Author: Bai, Guannan; Zhang, Lin; Zhao, Manli; Zhang, Jingyao; Chen, Wenhao

Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2026; Vol. 45, Issue 1, pp. -. DOI: 10.1186/s13046-026-03691-w